Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon
A major component of physiologically based pharmacokinetic (PBPK) models is the prediction of the rate and extent of absorption of orally dosed drugs for which knowledge of effective passive intestinal permeability (Peff) is essential. Single‐pass intestinal perfusion (SPIP) studies are used to esta...
Gespeichert in:
Veröffentlicht in: | Biopharmaceutics & drug disposition 2017-03, Vol.38 (2), p.94-114 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 114 |
---|---|
container_issue | 2 |
container_start_page | 94 |
container_title | Biopharmaceutics & drug disposition |
container_volume | 38 |
creator | Pade, D. Jamei, M. Rostami‐Hodjegan, A. Turner, D.B. |
description | A major component of physiologically based pharmacokinetic (PBPK) models is the prediction of the rate and extent of absorption of orally dosed drugs for which knowledge of effective passive intestinal permeability (Peff) is essential. Single‐pass intestinal perfusion (SPIP) studies are used to establish effective permeability in vivo but are difficult to perform in rodents, while mechanistic models to predict drug Peff in rat and mouse have not been published. This work evaluates the predictive performance of the ‘MechPeff’ model to predict Peff in the rodent intestine based upon knowledge of regional gut physiology and drug‐specific physicochemical parameters. The ‘MechPeff’ model, built‐in to the Simcyp Rat and Mouse Simulators, predicts transcellular, paracellular and mucus layer permeabilities and combines these to give the overall Peff. The jejunal and/or ileal Peff was predicted for 12 (4) acidic, 13 (12) basic, 10 (8) neutral and 2 (0) ampholytic drugs in the rat (mouse), spanning a wide range of MW and logPo:w, and compared with experimental Peff obtained using SPIP. A key input is the intrinsic transcellular permeability (Ptrans,0) which can be derived from modelling of appropriate in vitro permeability experiments or predicted from physicochemical properties. The Peff predictions were reasonably good when experimentally derived Ptrans,0 was used; from 42 Peff,rat values, 24 (57%) were within 3‐fold, and of 19 Peff,mouse values, 12 (63%) were within 3‐fold, of observed Peff. Considering the lack of alternative models to predict Peff in preclinical species, and the minimal drug‐specific inputs required, this model provides a valuable tool within drug discovery and development programmes. Copyright © 2017 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/bdd.2072 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1879191657</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4321068681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4152-24cca346b6c095a2b737f63b5d9ca85f0df3da0062304cc7ae9ef79efae0eb1d3</originalsourceid><addsrcrecordid>eNp1kctKJTEQhoPMoGdU8AkkMBs3rZX0Jd1LL3MDh5mFgrsmnVQ0ku60SY5ynmRed3I8XmBgFiGh8vFVFT8hBwyOGQA_GbQ-5iD4Flkw6LoCWnbzgSyAVbzgouU75FOM9wDQMMa2yQ5vOavKFhbkz-k8O6tksn6i3tB0h_QnqrvfaAwdvUZHk6dzQG1VorOM0T4izZ-o0vplp4Qx2Uk6OmMYUQ7W2bTK9WeVtpkMOCUa8Da3iK89Qlbnahylc28SpHLSVHnnpz3y0UgXcf_l3iXXX79cnX8vLn99-3F-elmoitV5uUopWVbN0CjoaskHUQrTlEOtOyXb2oA2pZZ5b15CRoXEDo3IRyLgwHS5S4423jn4h2Weoh9tVOicnNAvY89a0bGONbXI6Od_0Hu_DHnzDSWqqoP6XaiCjzGg6edgRxlWPYN-HVafw-rXYWX08EW4HEbUb-BrOhkoNsCTdbj6r6g_u7h4Fv4Fck2gaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1879744905</pqid></control><display><type>article</type><title>Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Pade, D. ; Jamei, M. ; Rostami‐Hodjegan, A. ; Turner, D.B.</creator><creatorcontrib>Pade, D. ; Jamei, M. ; Rostami‐Hodjegan, A. ; Turner, D.B.</creatorcontrib><description>A major component of physiologically based pharmacokinetic (PBPK) models is the prediction of the rate and extent of absorption of orally dosed drugs for which knowledge of effective passive intestinal permeability (Peff) is essential. Single‐pass intestinal perfusion (SPIP) studies are used to establish effective permeability in vivo but are difficult to perform in rodents, while mechanistic models to predict drug Peff in rat and mouse have not been published. This work evaluates the predictive performance of the ‘MechPeff’ model to predict Peff in the rodent intestine based upon knowledge of regional gut physiology and drug‐specific physicochemical parameters. The ‘MechPeff’ model, built‐in to the Simcyp Rat and Mouse Simulators, predicts transcellular, paracellular and mucus layer permeabilities and combines these to give the overall Peff. The jejunal and/or ileal Peff was predicted for 12 (4) acidic, 13 (12) basic, 10 (8) neutral and 2 (0) ampholytic drugs in the rat (mouse), spanning a wide range of MW and logPo:w, and compared with experimental Peff obtained using SPIP. A key input is the intrinsic transcellular permeability (Ptrans,0) which can be derived from modelling of appropriate in vitro permeability experiments or predicted from physicochemical properties. The Peff predictions were reasonably good when experimentally derived Ptrans,0 was used; from 42 Peff,rat values, 24 (57%) were within 3‐fold, and of 19 Peff,mouse values, 12 (63%) were within 3‐fold, of observed Peff. Considering the lack of alternative models to predict Peff in preclinical species, and the minimal drug‐specific inputs required, this model provides a valuable tool within drug discovery and development programmes. Copyright © 2017 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0142-2782</identifier><identifier>EISSN: 1099-081X</identifier><identifier>DOI: 10.1002/bdd.2072</identifier><identifier>PMID: 28214380</identifier><identifier>CODEN: BDDID8</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Administration, Oral ; Animals ; bile salts ; Colon - anatomy & histology ; Colon - metabolism ; Diffusion ; Drug Discovery - methods ; gut morphology ; High-Throughput Screening Assays ; Intestinal Absorption ; Intestinal Mucosa - anatomy & histology ; Intestinal Mucosa - metabolism ; Intestine, Small - anatomy & histology ; Intestine, Small - metabolism ; mechanistic prediction ; MechPeff ; Mice ; Models, Biological ; Permeability ; Pharmaceutical Preparations - administration & dosage ; Pharmaceutical Preparations - metabolism ; Pharmacokinetics ; Rats, Sprague-Dawley ; Reproducibility of Results ; rodent intestinal permeability</subject><ispartof>Biopharmaceutics & drug disposition, 2017-03, Vol.38 (2), p.94-114</ispartof><rights>Copyright © 2017 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4152-24cca346b6c095a2b737f63b5d9ca85f0df3da0062304cc7ae9ef79efae0eb1d3</citedby><cites>FETCH-LOGICAL-c4152-24cca346b6c095a2b737f63b5d9ca85f0df3da0062304cc7ae9ef79efae0eb1d3</cites><orcidid>0000-0003-0709-9528 ; 0000-0003-3917-844X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbdd.2072$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbdd.2072$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27926,27927,45576,45577</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28214380$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pade, D.</creatorcontrib><creatorcontrib>Jamei, M.</creatorcontrib><creatorcontrib>Rostami‐Hodjegan, A.</creatorcontrib><creatorcontrib>Turner, D.B.</creatorcontrib><title>Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon</title><title>Biopharmaceutics & drug disposition</title><addtitle>Biopharm Drug Dispos</addtitle><description>A major component of physiologically based pharmacokinetic (PBPK) models is the prediction of the rate and extent of absorption of orally dosed drugs for which knowledge of effective passive intestinal permeability (Peff) is essential. Single‐pass intestinal perfusion (SPIP) studies are used to establish effective permeability in vivo but are difficult to perform in rodents, while mechanistic models to predict drug Peff in rat and mouse have not been published. This work evaluates the predictive performance of the ‘MechPeff’ model to predict Peff in the rodent intestine based upon knowledge of regional gut physiology and drug‐specific physicochemical parameters. The ‘MechPeff’ model, built‐in to the Simcyp Rat and Mouse Simulators, predicts transcellular, paracellular and mucus layer permeabilities and combines these to give the overall Peff. The jejunal and/or ileal Peff was predicted for 12 (4) acidic, 13 (12) basic, 10 (8) neutral and 2 (0) ampholytic drugs in the rat (mouse), spanning a wide range of MW and logPo:w, and compared with experimental Peff obtained using SPIP. A key input is the intrinsic transcellular permeability (Ptrans,0) which can be derived from modelling of appropriate in vitro permeability experiments or predicted from physicochemical properties. The Peff predictions were reasonably good when experimentally derived Ptrans,0 was used; from 42 Peff,rat values, 24 (57%) were within 3‐fold, and of 19 Peff,mouse values, 12 (63%) were within 3‐fold, of observed Peff. Considering the lack of alternative models to predict Peff in preclinical species, and the minimal drug‐specific inputs required, this model provides a valuable tool within drug discovery and development programmes. Copyright © 2017 John Wiley & Sons, Ltd.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>bile salts</subject><subject>Colon - anatomy & histology</subject><subject>Colon - metabolism</subject><subject>Diffusion</subject><subject>Drug Discovery - methods</subject><subject>gut morphology</subject><subject>High-Throughput Screening Assays</subject><subject>Intestinal Absorption</subject><subject>Intestinal Mucosa - anatomy & histology</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Intestine, Small - anatomy & histology</subject><subject>Intestine, Small - metabolism</subject><subject>mechanistic prediction</subject><subject>MechPeff</subject><subject>Mice</subject><subject>Models, Biological</subject><subject>Permeability</subject><subject>Pharmaceutical Preparations - administration & dosage</subject><subject>Pharmaceutical Preparations - metabolism</subject><subject>Pharmacokinetics</subject><subject>Rats, Sprague-Dawley</subject><subject>Reproducibility of Results</subject><subject>rodent intestinal permeability</subject><issn>0142-2782</issn><issn>1099-081X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKJTEQhoPMoGdU8AkkMBs3rZX0Jd1LL3MDh5mFgrsmnVQ0ku60SY5ynmRed3I8XmBgFiGh8vFVFT8hBwyOGQA_GbQ-5iD4Flkw6LoCWnbzgSyAVbzgouU75FOM9wDQMMa2yQ5vOavKFhbkz-k8O6tksn6i3tB0h_QnqrvfaAwdvUZHk6dzQG1VorOM0T4izZ-o0vplp4Qx2Uk6OmMYUQ7W2bTK9WeVtpkMOCUa8Da3iK89Qlbnahylc28SpHLSVHnnpz3y0UgXcf_l3iXXX79cnX8vLn99-3F-elmoitV5uUopWVbN0CjoaskHUQrTlEOtOyXb2oA2pZZ5b15CRoXEDo3IRyLgwHS5S4423jn4h2Weoh9tVOicnNAvY89a0bGONbXI6Od_0Hu_DHnzDSWqqoP6XaiCjzGg6edgRxlWPYN-HVafw-rXYWX08EW4HEbUb-BrOhkoNsCTdbj6r6g_u7h4Fv4Fck2gaA</recordid><startdate>201703</startdate><enddate>201703</enddate><creator>Pade, D.</creator><creator>Jamei, M.</creator><creator>Rostami‐Hodjegan, A.</creator><creator>Turner, D.B.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0709-9528</orcidid><orcidid>https://orcid.org/0000-0003-3917-844X</orcidid></search><sort><creationdate>201703</creationdate><title>Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon</title><author>Pade, D. ; Jamei, M. ; Rostami‐Hodjegan, A. ; Turner, D.B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4152-24cca346b6c095a2b737f63b5d9ca85f0df3da0062304cc7ae9ef79efae0eb1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>bile salts</topic><topic>Colon - anatomy & histology</topic><topic>Colon - metabolism</topic><topic>Diffusion</topic><topic>Drug Discovery - methods</topic><topic>gut morphology</topic><topic>High-Throughput Screening Assays</topic><topic>Intestinal Absorption</topic><topic>Intestinal Mucosa - anatomy & histology</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Intestine, Small - anatomy & histology</topic><topic>Intestine, Small - metabolism</topic><topic>mechanistic prediction</topic><topic>MechPeff</topic><topic>Mice</topic><topic>Models, Biological</topic><topic>Permeability</topic><topic>Pharmaceutical Preparations - administration & dosage</topic><topic>Pharmaceutical Preparations - metabolism</topic><topic>Pharmacokinetics</topic><topic>Rats, Sprague-Dawley</topic><topic>Reproducibility of Results</topic><topic>rodent intestinal permeability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pade, D.</creatorcontrib><creatorcontrib>Jamei, M.</creatorcontrib><creatorcontrib>Rostami‐Hodjegan, A.</creatorcontrib><creatorcontrib>Turner, D.B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biopharmaceutics & drug disposition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pade, D.</au><au>Jamei, M.</au><au>Rostami‐Hodjegan, A.</au><au>Turner, D.B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon</atitle><jtitle>Biopharmaceutics & drug disposition</jtitle><addtitle>Biopharm Drug Dispos</addtitle><date>2017-03</date><risdate>2017</risdate><volume>38</volume><issue>2</issue><spage>94</spage><epage>114</epage><pages>94-114</pages><issn>0142-2782</issn><eissn>1099-081X</eissn><coden>BDDID8</coden><abstract>A major component of physiologically based pharmacokinetic (PBPK) models is the prediction of the rate and extent of absorption of orally dosed drugs for which knowledge of effective passive intestinal permeability (Peff) is essential. Single‐pass intestinal perfusion (SPIP) studies are used to establish effective permeability in vivo but are difficult to perform in rodents, while mechanistic models to predict drug Peff in rat and mouse have not been published. This work evaluates the predictive performance of the ‘MechPeff’ model to predict Peff in the rodent intestine based upon knowledge of regional gut physiology and drug‐specific physicochemical parameters. The ‘MechPeff’ model, built‐in to the Simcyp Rat and Mouse Simulators, predicts transcellular, paracellular and mucus layer permeabilities and combines these to give the overall Peff. The jejunal and/or ileal Peff was predicted for 12 (4) acidic, 13 (12) basic, 10 (8) neutral and 2 (0) ampholytic drugs in the rat (mouse), spanning a wide range of MW and logPo:w, and compared with experimental Peff obtained using SPIP. A key input is the intrinsic transcellular permeability (Ptrans,0) which can be derived from modelling of appropriate in vitro permeability experiments or predicted from physicochemical properties. The Peff predictions were reasonably good when experimentally derived Ptrans,0 was used; from 42 Peff,rat values, 24 (57%) were within 3‐fold, and of 19 Peff,mouse values, 12 (63%) were within 3‐fold, of observed Peff. Considering the lack of alternative models to predict Peff in preclinical species, and the minimal drug‐specific inputs required, this model provides a valuable tool within drug discovery and development programmes. Copyright © 2017 John Wiley & Sons, Ltd.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28214380</pmid><doi>10.1002/bdd.2072</doi><tpages>21</tpages><orcidid>https://orcid.org/0000-0003-0709-9528</orcidid><orcidid>https://orcid.org/0000-0003-3917-844X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0142-2782 |
ispartof | Biopharmaceutics & drug disposition, 2017-03, Vol.38 (2), p.94-114 |
issn | 0142-2782 1099-081X |
language | eng |
recordid | cdi_proquest_miscellaneous_1879191657 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Administration, Oral Animals bile salts Colon - anatomy & histology Colon - metabolism Diffusion Drug Discovery - methods gut morphology High-Throughput Screening Assays Intestinal Absorption Intestinal Mucosa - anatomy & histology Intestinal Mucosa - metabolism Intestine, Small - anatomy & histology Intestine, Small - metabolism mechanistic prediction MechPeff Mice Models, Biological Permeability Pharmaceutical Preparations - administration & dosage Pharmaceutical Preparations - metabolism Pharmacokinetics Rats, Sprague-Dawley Reproducibility of Results rodent intestinal permeability |
title | Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T12%3A44%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Application%20of%20the%20MechPeff%20model%20to%20predict%20passive%20effective%20intestinal%20permeability%20in%20the%20different%20regions%20of%20the%20rodent%20small%20intestine%20and%20colon&rft.jtitle=Biopharmaceutics%20&%20drug%20disposition&rft.au=Pade,%20D.&rft.date=2017-03&rft.volume=38&rft.issue=2&rft.spage=94&rft.epage=114&rft.pages=94-114&rft.issn=0142-2782&rft.eissn=1099-081X&rft.coden=BDDID8&rft_id=info:doi/10.1002/bdd.2072&rft_dat=%3Cproquest_cross%3E4321068681%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1879744905&rft_id=info:pmid/28214380&rfr_iscdi=true |